These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 2539153)
1. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153 [TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils. Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of calyculin A and okadaic acid on the glucose-induced regulation of glycogen synthase and phosphorylase activities in cultured hepatocytes. Pugazhenthi S; Yu B; Gali RR; Khandelwal RL Biochim Biophys Acta; 1993 Nov; 1179(3):271-6. PubMed ID: 8218371 [TBL] [Abstract][Full Text] [Related]
4. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Verin AD; Patterson CE; Day MA; Garcia JG Am J Physiol; 1995 Jul; 269(1 Pt 1):L99-108. PubMed ID: 7631821 [TBL] [Abstract][Full Text] [Related]
5. Protein phosphatase inhibitors, okadaic acid and calyculin A, induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria. Murata T; Shirakawa S; Takehara T; Kobayashi S; Haneji T Biochem Mol Biol Int; 1995 Jun; 36(2):365-72. PubMed ID: 7663440 [TBL] [Abstract][Full Text] [Related]
6. A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle. Hori M; Magae J; Han YG; Hartshorne DJ; Karaki H FEBS Lett; 1991 Jul; 285(1):145-8. PubMed ID: 1648511 [TBL] [Abstract][Full Text] [Related]
7. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction. Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase. Lerea KM Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663 [TBL] [Abstract][Full Text] [Related]
9. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Suganuma M; Fujiki H; Okabe S; Nishiwaki S; Brautigan D; Ingebritsen TS; Rosner MR Toxicon; 1992 Aug; 30(8):873-8. PubMed ID: 1326138 [TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance. Chambers TC; Raynor RL; Kuo JF Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882 [TBL] [Abstract][Full Text] [Related]
11. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A. Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116 [TBL] [Abstract][Full Text] [Related]
13. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A. Weller M; Malipiero U; Groscurth P; Fontana A Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor. Koch B; Lutz-Bucher B Cell Signal; 1994 May; 6(4):467-73. PubMed ID: 7946970 [TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A. Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901 [TBL] [Abstract][Full Text] [Related]
16. Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A. Nishikawa M; Toyoda H; Saito M; Morita K; Tawara I; Deguchi K; Kuno T; Shima H; Nagao M; Shirakawa S Cell Signal; 1994 Jan; 6(1):59-71. PubMed ID: 8011429 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Bialojan C; Takai A Biochem J; 1988 Nov; 256(1):283-90. PubMed ID: 2851982 [TBL] [Abstract][Full Text] [Related]
18. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid. Tanaka H; Katagiri M; Arima S; Matsuzaki K; Inokoshi J; Omura S Biochem Biophys Res Commun; 1995 Nov; 216(1):291-7. PubMed ID: 7488103 [TBL] [Abstract][Full Text] [Related]
19. The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Jordan NJ; Watson ML; Westwick J Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):89-95. PubMed ID: 7575485 [TBL] [Abstract][Full Text] [Related]
20. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets. Tamagawa T; Iguchi A; Uemura K; Miura H; Nonogaki K; Ishiguro T; Sakamoto N Endocrinol Jpn; 1992 Jun; 39(3):325-9. PubMed ID: 1330503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]